
Sign up to save your podcasts
Or
Dana Brown, President and CEO of iCAD, a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions joins eHealth Radio and the Cancer Prevention and Health News Channels.
Listen to interview with host Eric Michaels & guest Dana Brown discuss the following:
A 30-year technology industry veteran, Dana Brown is currently as President and CEO of iCAD. She previously served as Senior Vice President, Chief Strategy and Operations Officer at Susan G. Komen and Senior Vice President and Chief Digital Officer at United Way Worldwide. Ms. Brown was also a founding team member of multiple successful ventures including co-founder and CMO for MetaSolv Software, CEO of Ipsum Networks and spent the early years of her career at Texas Instruments and Arthur Andersen.
Website: https://www.icadmed.com
Social Media Links:
People also listened to this: How Specialists & General Providers Together Can Drive Early Detection of MASLD/MASH to Transform Patients’ Liver Health
5
1010 ratings
Dana Brown, President and CEO of iCAD, a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions joins eHealth Radio and the Cancer Prevention and Health News Channels.
Listen to interview with host Eric Michaels & guest Dana Brown discuss the following:
A 30-year technology industry veteran, Dana Brown is currently as President and CEO of iCAD. She previously served as Senior Vice President, Chief Strategy and Operations Officer at Susan G. Komen and Senior Vice President and Chief Digital Officer at United Way Worldwide. Ms. Brown was also a founding team member of multiple successful ventures including co-founder and CMO for MetaSolv Software, CEO of Ipsum Networks and spent the early years of her career at Texas Instruments and Arthur Andersen.
Website: https://www.icadmed.com
Social Media Links:
People also listened to this: How Specialists & General Providers Together Can Drive Early Detection of MASLD/MASH to Transform Patients’ Liver Health